Real Estate
Filter News
Found 6,906 articles
-
Marker Therapeutics Announces Completion of New Manufacturing Facility to Support Clinical Development of MultiTAA-Specific T Cell Therapy Product Candidates
1/13/2021
Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that it has completed the construction and qualification of its cGMP manufacturing facility in Houston, TX, located near the George Bush Intercontinental Airport
-
Rocket Pharmaceuticals Announces Buildout of R&D and Manufacturing Facility to Support Development of Innovative Gene Therapy Pipeline
1/11/2021
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces the Company’s plans for the buildout of its new Research and Development (R&D) and Chemistry, Manufacturing and Controls (CMC) operation which will also serve as the Company’s new headquarters in Cranbury, New Jersey
-
Leukocare starts operations in the US and opens development laboratories and offices in Boston Metropolitan Area
1/11/2021
Leukocare AG, a German biotechnology company specialized in formulation development for biologics, viral vectors and vaccines, announced the opening of its development laboratories and offices in Milford, MA, USA.
-
Morrisville, North Carolina, has reason to hope that it may be the beneficiary of Fujifilm’s next major investment, a $2 Billion USD large-scale cell culture manufacturing site which the company said will be located near one of its current facilities.
-
Process development and quality control will begin in 2021, and full manufacturing capabilities at the 88,000-square-foot facility will be available in 2023.
-
Explora BioLabs to Open Its First East Coast Facility in Boston
1/7/2021
Explora BioLabs, the nation's largest provider of pre-clinical vivarium, husbandry, and research space, will launch its first East Coast facility here in mid-2021.
-
TheraLight Announces Relocation and Expansion for New Corporate Headquarters
1/7/2021
TheraLight, LLC, a privately held U.S.-based medical device company specializing in photomedicine, announced the relocation and expansion of its corporate headquarters to a new office and warehouse in Lindon, Utah to advance the operations and growth of the company.
-
2021 is off to a hopeful start for some companies, executives and scientists, while others are forced to fold programs and recalibrate.
-
BioMed Realty Acquires Flagship Property in Boston’s Seaport District
1/6/2021
601 Congress Street further builds on developer's premier life science real estate portfolio in Boston/Cambridge
-
The new process development and manufacturing facility will focus on viral vectors and advanced therapies. It is the third location for Diosynth’s CDMO viral vector services.
-
Oncorus to Build GMP Viral Immunotherapy Clinical Manufacturing Facility in Andover, Mass.
1/4/2021
88,000 square foot state-of-the-art facility will support Oncorus’ advancing, multi-product pipeline of intratumorally and intravenously administered viral immunotherapies
-
Presidio Bay Ventures partnered with Kinship Capital to acquire a piece of property in the Northern California city to redevelop into a space for the life sciences industry.
-
The new state-of-the-art facility, dubbed the “Factory of the Future,” will span 110,000 square feet and will be located in the city of Wilsonville, Oregon.
-
Briotech, Inc. Expands to 82,000 SF Class-A Wesmar Building in Woodinville
12/23/2020
Briotech, Inc. announces manufacturing expansion to meet demand for its BrioHOCl® and BrioWHISH™ (patent pending) Networked Production Systems
-
Tonix Pharmaceuticals Plans Commercial Scale Vaccine Manufacturing Facility
12/23/2020
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that it has completed the purchase of an approximately 44-acre site in Hamilton, Montana, for the construction of a vaccine development and commercial scale manufacturing facilit
-
Golden State Dermatology Announces Two New San Francisco Bay Area Locations
12/21/2020
Golden State Dermatology is pleased to announce Minh Dang, M.D., F.A.A.D. and her team have joined Golden State Dermatology.
-
KYOCERA to Construct New R&D Center in Kirishima City, Kagoshima, Japan
12/18/2020
Kyocera Corporation announced it will begin construction of a new research and development center in January 2021 at its Kokubu campus in Kirishima City, Kagoshima, Japan.
-
The company is significantly expanding its footprint with new facilities in the United States and in Europe.
-
Taysha Gene Therapies Announces New cGMP Gene Therapy Manufacturing Facility
12/17/2020
Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations, today announced that it has entered into a lease agreement to occupy and configure an approximately 187,000-square-foot commercial-scale current Good Manufacturing Practices
-
SHINE Medical Breaks Ground for 54,000-Square-Foot Headquarters and Therapeutics Production Facility
12/16/2020
SHINE Medical Technologies LLC announced that the company has broken ground on a new 54,000-square-foot facility that will house its corporate headquarters and a large-scale production facility for the Therapeutics division it established last year.